ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,763 | -14.5% | 14,046 | +20.2% | 0.00% | -33.3% |
| Q2 2023 | $329,577 | +44.9% | 11,683 | -11.7% | 0.00% | +50.0% |
| Q1 2023 | $227,522 | -12.2% | 13,228 | +2.8% | 0.00% | -33.3% |
| Q4 2022 | $259,061 | -3.3% | 12,863 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $268,000 | -22.8% | 12,383 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $347,000 | +22.6% | 12,349 | +101.7% | 0.00% | +50.0% |
| Q1 2022 | $283,000 | -44.5% | 6,123 | +1.0% | 0.00% | -50.0% |
| Q4 2021 | $510,000 | +36.0% | 6,063 | +7.7% | 0.00% | +33.3% |
| Q3 2021 | $375,000 | +27.6% | 5,627 | +1.9% | 0.00% | +50.0% |
| Q2 2021 | $294,000 | +27.3% | 5,520 | +3.8% | 0.00% | 0.0% |
| Q1 2021 | $231,000 | -14.8% | 5,320 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $271,000 | – | 5,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |